You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
春立醫療(01858.HK)擬向銀行申請不超5億元綜合授信額度
格隆匯 01-18 21:55

格隆匯1月18日丨春立醫療(01858.HK)公吿,北京市春立正達醫療器械股份有限公司(以下簡稱“公司”)於2022年1月18日分別召開了第四屆董事會第十六次會議、第四屆監事會第四次會議,會議審議通過了《關於向銀行申請綜合授信額度的議案》。現將具體情況公吿如下:

為滿足經營發展的需要,公司擬向北京銀行股份有限公司、中國銀行股份有限公司、中國建設銀行股份有限公司等銀行共計申請不超過人民幣5億元的綜合授信額度,授信種類包括但不限於流動資金貸款、固定資產貸款、銀行承兑匯票、信用證、貼現、保理、保函、抵(質)押貸款等各種融資業務。本次申請授信額度有效期為:自董事會審議通過日起12個月內。在授信期限內,授信額度可循環使用。具體授信業務品種、額度和期限以銀行最終核定為準。

以上授信不等於公司的實際融資金額,實際融資金額應在授信額度內,並以銀行與公司實際發生的融資金額為準。具體融資金額及品種將視公司業務發展的實際需求來合理確定。公司本次向銀行申請綜合授信額度事項不涉及對外擔保或關聯交易,該議案無需提交公司股東大會審議。公司董事會授權法定代表人或其指定的授權代理人根據業務開展情況在上述授權額度範圍內行使決策權與簽署相關法律文件,並由公司財務部負責具體實施。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account